Page 41 of Health and Medical News issued by the Send2Press® Newswire service.
| From: Stratosphere Partners LLC
BOSTON, Mass.- May 5 (SEND2PRESS NEWSWIRE) — Stratosphere Partners LLC, a Knowledge Venturing(tm) company that specializes in building new platform businesses and UV Solutions LLC, a pioneer of UV flash disinfection technologies today announce that they have formed a partnership to build a UV disinfection platform and brand based on UV Solutions’ patented technology.
| From: Exceptional Resources, Inc.
DALLAS, TX and ALBERTA, Canada – April 27 (SEND2PRESS NEWSWIRE) — Autism Today announces a live, interactive telephone conference will be held from 6:00 – 8:00 PST this Thursday, April 28th featuring David Kirby, author of ‘Evidence of Harm, A Medical Controversy’ (ISBN: 0-312-32544-0). He will address the question: ‘Does mercury in vaccines cause autism and other disorders in children?’
| From: Special Abilities, Inc.
SALT LAKE CITY, UT — (SEND2PRESS NEWSWIRE) — Reports of a new study by Special Abilities, Inc. send an alarming message to parents of young infants and children. Pediatricians are not recognizing the symptoms of Autism Spectrum Disorder (ASD) at an early age denying children benefits of early intervention and therapy. Autism is a complex neurological disorder characterized by profound delays in communication and social interaction and affects over 1.7 million individuals in the U.S.
| From: Sprixx, DBA of Harbor Medical, Inc.
SANTA BARBARA, Calif. — (SEND2PRESS NEWSWIRE) — The nation’s top hospital infection fighters will be getting a look at a new breakthrough ergonomic hand sanitizer that holds the promise of preventing 20,000 to 50,000 U.S. deaths each year. Sprixx is an alcohol hand sanitizer dispenser that you wear, use on-the-go, and is ergonomically designed to become a second-nature habit in use.
| From: Epeius Biotechnologies Corporation
LOS ANGELES, Calif. — (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corp. announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer.
| From: Epeius Biotechnologies Corporation
LOS ANGELES, Calif. — (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation (www.epeiusbiotech.com) announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer. In 2003, Rexin-G gained FDA approval as an Orphan Drug based on clinical demonstrations of the medical utility of Rexin-G as an effective treatment for pancreatic cancer.
| From: Medical Management Services Group (MMSG)
POUGHKEEPSIE, NY /Send2Press Newswire/ — Satish. S. Modi, M.D., F.R.C.S. ( C ) a leading ophthalmic surgeon in Poughkeepsie, New York has been selected by Alcon Laboratories as one of a limited number of surgeons to begin implanting its AcrySoft(R) ReSTOR(R) Intraocular Lens (IOL) for cataract patients with and without presbyopia.
| From: Greater Northwest Medical Group, S.C.
BUFFALO GROVE, IL /Send2Press Newswire/ — Greater Northwest Medical Group, including eleven Internal Medicine and Family Practice physicians, treating patients at its Buffalo Grove, Arlington Heights, and Park Ridge offices, announces its transition from traditional paper medical charts to Electronic Medical Records (EMR).
| From: Kaplan Cosmetic Surgery, Inc.
WINTER PARK, FL /Send2Press Newswire/ — Kaplan Cosmetic Surgery, Inc. is pleased to announce that its founder and director, Barry J. Kaplan, D.O., was published in the June 2004 issue of the Journal of the American Academy of Cosmetic Surgery for an original article.
| From: Global Medical Research, LLC
ORLANDO, FL /Send2Press Newswire/ — Global Medical Research, LLC (www.gmrllc.com), a Central Florida-based company dedicated to developing and commercializing intellectual properties that address problems in the biomedical field, today announced the launch of breakthrough technology designed to prevent post surgical adhesions. GMR’s Internal-Tissue Engineered Membrane Product (i-TEMP(tm)), is now poised for advanced phase animal testing to support the expectations of a broad spectrum of uses.
| From: UVSolutions LLC
BOSTON, MA /Send2Press Newswire/ — Ultraviolet disinfection technology developed for hospital-use now available for a number of home and personal care products such as toothbrushes, pacifiers, drinking cups, knives, cutting boards, etc. reports UVSolutions, LLC (www.uvs-ultraclean.com).
| From: Sprixx, DBA of Harbor Medical, Inc.
SANTA BARBARA, Calif. /Send2Press Newswire/ — Sprixx (www.sprixx.com), a DBA of Harbor Medical, Inc., has announced the availability of a new unscented alcohol hand sanitizer formula for its line of professional body-worn hand sanitizers. Containing 63% ethyl alcohol with emollients, the new product is available for the popular Sprixx XE Dispenser which is delivered in a 1.35-ounce replacement cartridge.
| From: ThyroTec, Inc.
HONEY BROOK, PA /Send2Press Newswire/ — Thanks to FDA approval of ThyroTest(tm), a new rapid hypothyroid diagnostic screening device from ThyroTec, Inc., detection of a common thyroid disease will now come sooner rather than later for millions of Americans. More Americans suffer from thyroid disease than diabetes and cancer combined.
